• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断其他原发性肿瘤患者的膀胱癌风险:SEER 数据库分析。

The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database.

机构信息

Department of Urologic Surgery, Biostatistical Consulting Laboratory, University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

Urol Oncol. 2013 Aug;31(6):862-5. doi: 10.1016/j.urolonc.2011.06.005. Epub 2011 Jul 23.

DOI:10.1016/j.urolonc.2011.06.005
PMID:21784673
Abstract

OBJECTIVE

We evaluated patients with history of previous malignancy to determine risk of an ensuing bladder cancer.

MATERIALS AND METHODS

The National Cancer Institute's Surveillance, Epidemiology, and End Results 9 registry database from 1973 to 1999 (SEER) was reviewed for patients with initial primary cancers in oral cavity and pharynx, colon and rectum, respiratory system, breast, prostate, testis, or penis. This group of patients was then examined to identify subsequent separate primary malignancies in the bladder. Comparison was made to the incidence of bladder cancer in the general population to determine a standardized incidence ratio (SIR). Additional analysis was performed based on age at diagnosis, stage, gender, race, and use of external beam radiation for treatment of initial cancer.

RESULTS

A total of 7,289 (0.5%) of patients had a bladder cancer following their initial malignancy. Patients with prostate cancer had the largest increase in risk of bladder cancer with a SIR of 8.24, and all initial cancer groups had an elevated risk of bladder cancer relative to the general population. External beam radiation and non-White gender were associated with an increased risk of bladder cancer. Older age at diagnosis of the initial cancer correlated with a lower risk of subsequent bladder cancer.

CONCLUSIONS

This study suggests an increased risk of bladder cancer following a separate initial cancer. Lower threshold for working up those patients for bladder cancer may be warranted.

摘要

目的

我们评估了有既往恶性肿瘤病史的患者,以确定随后发生膀胱癌的风险。

材料与方法

回顾了 1973 年至 1999 年期间美国国家癌症研究所的监测、流行病学和结果 9 号登记数据库(SEER)中,口腔和咽、结肠和直肠、呼吸系统、乳腺、前列腺、睾丸或阴茎的初始原发性癌症患者的资料。然后,对这群患者进行了检查,以确定随后是否有单独的原发性膀胱癌。将其与一般人群中膀胱癌的发病率进行比较,以确定标准化发病率比(SIR)。根据诊断时的年龄、分期、性别、种族以及初始癌症的外部束放疗的使用情况,进行了额外的分析。

结果

共有 7289 名(0.5%)患者在初次恶性肿瘤后发生了膀胱癌。前列腺癌患者膀胱癌的风险增加最大,SIR 为 8.24,所有初始癌症组与一般人群相比,膀胱癌的风险均升高。外部束放疗和非白人种性别与膀胱癌风险增加相关。初始癌症诊断时的年龄越大,随后发生膀胱癌的风险越低。

结论

本研究表明,在单独的初始癌症后发生膀胱癌的风险增加。对于这些患者,可能需要更严格地筛查膀胱癌。

相似文献

1
The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database.诊断其他原发性肿瘤患者的膀胱癌风险:SEER 数据库分析。
Urol Oncol. 2013 Aug;31(6):862-5. doi: 10.1016/j.urolonc.2011.06.005. Epub 2011 Jul 23.
2
Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.随着年龄的增长和治疗方式的改变,前列腺癌患者在确诊后更容易被诊断出膀胱癌。
Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1086-94. doi: 10.1016/j.ijrobp.2009.09.055. Epub 2010 Mar 28.
3
A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.基于人群的子宫内膜癌后继发原发性恶性肿瘤研究:遗传、环境和治疗相关因素的关联。
Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):127-35. doi: 10.1016/j.ijrobp.2009.07.1692. Epub 2009 Nov 10.
4
Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.前列腺癌接受原发及辅助外照射放疗后的膀胱癌风险。
J Urol. 2005 Jul;174(1):107-10; discussion 110-1. doi: 10.1097/01.ju.0000163459.57305.a1.
5
Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.前列腺癌放射治疗会增加后续患膀胱癌和直肠癌的风险:一项基于人群的队列研究。
J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. doi: 10.1016/j.juro.2008.07.038. Epub 2008 Sep 17.
6
Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.前列腺近距离放射治疗后的第二原发性恶性肿瘤:15年潜在随访期患者膀胱癌和结直肠癌的发病率
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):669-73. doi: 10.1016/j.ijrobp.2006.05.016. Epub 2006 Aug 2.
7
Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.蕈样肉芽肿和塞扎里综合征患者的继发性淋巴瘤及其他恶性肿瘤:基于人群和临床队列的证据
Arch Dermatol. 2007 Jan;143(1):45-50. doi: 10.1001/archderm.143.1.45.
8
High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.膀胱非肌层浸润性移行细胞癌后肺癌的高发病率:对筛查试验的启示
Clin Lung Cancer. 2008 Mar;9(2):106-11. doi: 10.3816/CLC.2008.n.016.
9
Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.膀胱癌中的第二原发性恶性肿瘤——一项基于人群的研究。
Anticancer Res. 2017 Apr;37(4):2033-2036. doi: 10.21873/anticanres.11548.
10
Higher than expected association of clinical prostate and bladder cancers.临床前列腺癌和膀胱癌的关联高于预期。
J Urol. 2005 May;173(5):1526-9. doi: 10.1097/01.ju.0000154700.80042.c6.

引用本文的文献

1
Dynamic changes of quality of life in muscle-invasive bladder cancer survivors.肌层浸润性膀胱癌幸存者生活质量的动态变化。
BMC Urol. 2022 Aug 20;22(1):126. doi: 10.1186/s12894-022-01084-7.
2
ctDNA facilitated the diagnosis of a patient with synchronous urothelial carcinoma and non-small cell lung cancer: case report.循环肿瘤DNA助力同步性尿路上皮癌和非小细胞肺癌患者的诊断:病例报告
Ann Transl Med. 2020 Oct;8(20):1323. doi: 10.21037/atm-20-6552.
3
Is there a role for IGF-1 in the development of second primary cancers?胰岛素样生长因子-1(IGF-1)在第二原发性癌症的发生发展中起作用吗?
Cancer Med. 2016 Nov;5(11):3353-3367. doi: 10.1002/cam4.871. Epub 2016 Oct 13.